Extended Data Fig. 13: Model predicted outcomes of TrkB cell inhibitor treatments are corroborated by cell images.

Live cell images of BDNF-stimulated TrkB cells treated with 2.5 μM Gefitinib, 0.2 μM Trametinib and a combination of 1.2 μM Gefitinib and 0.1 μM Trametinib at 72 h. Representative images of 3 biological replicates are shown.